Canaccord Genuity analyst Dewey Steadman maintained a Hold rating on TLTeligent Inc (NYSE: TLGT) today and set a price target of $3.50. The company’s shares opened today at $3.45, close to its 52-week low of $2.43.
According to TipRanks.com, Steadman is a 3-star analyst with an average return of 4.9% and a 47.4% success rate. Steadman covers the Healthcare sector, focusing on stocks such as ANI Pharmaceuticals Inc, Pacira Pharmaceuticals, and Perrigo Company plc.
Currently, the analyst consensus on TLTeligent Inc is a Hold with an average price target of $3.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $9.27 and a one-year low of $2.43. Currently, TLTeligent Inc has an average volume of 712.6K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.
